NCT04758026View on ClinicalTrials.gov

H&N Cancer; Survivorship and Late Effects

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

October 10, 2020

Study Completion Date

October 10, 2020

Conditions
Head and Neck NeoplasmsSurvivorship
Trial Locations (1)

N-0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT04758026 - H&N Cancer; Survivorship and Late Effects | Biotech Hunter | Biotech Hunter